Sugi Predict

Sugi Predict / Compounds / SCHEMBL344615

SCHEMBL344615

SCHEMBL344615

CCC(O)OC(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.55
▸ TP53 P04637 1/20 0.55
▸ LMNA P02545 4/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ PDCD1 Q15116 1/20 0.49
▸ CD274 Q9NZQ7 1/20 0.49
▸ F2 P00734 1/20 0.48
▸ NPC1 O15118 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ PRKCA P17252 1/20 0.45
▸ ADRB2 P07550 2/20 0.45
▸ ADRB1 P08588 2/20 0.45
▸ ADRB3 P13945 2/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ SCN1A P35498 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962888 0.90 CA12 (0.48) TSHRTP53LMNAALDH1A1PDCD1
SCHEMBL2160586 0.87 MAPT (0.56) TSHRTP53ALDH1A1PDCD1CD274
SCHEMBL3088428 0.87 MAPT (0.43) TSHRTP53NPC1HTTRAB9A
SCHEMBL525355 0.85 LMNA (0.53) TSHRTP53LMNAALDH1A1PDCD1
SCHEMBL9989638 0.84 KMT2A (0.46) TP53ALDH1A1NPC1HTTRAB9A
SCHEMBL10765866 0.83 CA12 (0.47) TSHRLMNAALDH1A1PDCD1CD274
SCHEMBL9513971 0.83 CA12 (0.61) TSHRLMNAALDH1A1NPC1RAB9A
SCHEMBL27821840 0.82 TSHR (0.57) TSHRTP53LMNAALDH1A1PDCD1
SCHEMBL1513963 0.82 TSHR (0.53) TSHRTP53LMNAALDH1A1NPC1
SCHEMBL416565 0.82 TSHR (0.57) TSHRTP53LMNAALDH1A1PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115252495-B Rosemary amino acid hair conditioner and preparation method thereof 河南迷迭香生物科技有限公司 2023-08-11 — — CN claimed
CN-1193751-C Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives KOREA INST ORIENTAL MEDICINE (KR) 2005-03-23 — — CN claimed
CN-1383381-A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives KOREA INST ORIENTAL MEDICINE (KR) 2002-12-04 — — CN claimed
US-12637470-B2 Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2026-05-26 — — US disclosed
EP-4735447-A1 AROMATIC NITROGEN-CONTAINING COMPOUNDS, PREPARATION METHODS AND MEDICINAL USES THEREOF Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2026-05-06 — — EP disclosed
CN-116916924-B MALT1 modulators and uses thereof 稀有生物科学股份有限公司 2026-02-27 — — CN disclosed
EP-4676428-A1 LIQUID UV FILTER COMPOSITION CONTAINING DIOLS Symrise AG (DE) 2026-01-14 — — EP disclosed
EP-4676433-A1 LIQUID UV FILTER CONCENTRATE Symrise AG (DE) 2026-01-14 — — EP disclosed
US-20250255883-A1 Compositions and Methods for Treating Aging Hair CHL INDUSTRIES, LLC 2025-08-14 — — US disclosed
CN-113999236-B Salt of nitrogen-containing heterocyclic compound and solid form, pharmaceutical composition and use of salt thereof 武汉人福创新药物研发中心有限公司 2025-06-10 — — CN disclosed
CN-113999235-B Solid forms of nitrogen-containing heterocyclic compounds, pharmaceutical compositions and uses thereof 武汉人福创新药物研发中心有限公司 2025-06-10 — — CN disclosed
US-4922004-A Copolymerizable photoinitiators Merck Patent Gesellschaft mit bescrankter Haftung (DE) 1990-05-01 — — US disclosed
US-4833035-A Oriented polymer materials MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-05-23 — — US disclosed
US-4822682-A Oriented polymer materials MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-04-18 — — US disclosed
US-4721734-A PHOTOPOLYMERIZATION OF UNSATURATED COMPOUNDS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1988-01-26 — — US disclosed
US-4496447-A PHOTOPOLYMERIZATION OF UNSATURATED COMPOUNDS AND FOR CURING PRINTING INKS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 1985-01-29 — — US disclosed
US-4477681-A PHOTOPOLYMERIZATION AND HARDENING OF PRINTING DYES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
US-4374984-A Aromatic-aliphatic ketones useful as photoinitiators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-02-22 — — US disclosed
US-4347111-A PHOTOPOLYMERIZATION OF UNSATURATED COMPOUNDS, HARDENING OF PRINTING DYES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1982-08-31 — — US disclosed
US-4223160-A NIOBIUM AND RUTHENIUM SALTS AS CATALYSTS UNION CARBIDE CORPORATION (US) 1980-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637470-B2 Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof ATXN10, ATXN2, ATXN2L TSHR 1939/4885TP53 3988/4885LMNA 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.